STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2020

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Schedule of weighted-average assumptions

The following table presents the weighted-average assumptions used to estimate the fair value of the stock options granted during the three months ended March 31, 2020:

Risk Free Interest Rate		1.78	%
Expected Volatility		453.90	%
Expected Life (in years)		5.0
Dividend Yield		0	%
Weighted average estimated fair value of
options during the period	$	0.10

The following table presents the weighted-average assumptions used to estimate the fair values of the stock options granted during the years ended December 31, 2019 and 2018:

	2019			2018
Risk Free Interest Rate		2.14	%		2.30	%
Expected Volatility		436.22	%		200.50	%
Expected Life (in years)		5.0			5.0
Dividend Yield		0	%		0	%
Weighted average estimated fair value of options during the period	$	0.25		$	0.17

Schedule of stock option activity

	Options Outstanding
					Weighted -
					Average		Aggregate
					Remaining		Intrinsic
			Weighted-		Contractual		Value
	Number of		Average		Term		(in 000’s)
	Shares		Exercise Price		(in years)		(1)
Balance as of December 31, 2019	17,913,529		$	0.12
Granted		4,700,000		0.07
Balance as of March 31, 2020		22,613,529	$	0.11
Exercisable as of March 31, 2020		20,088,529	$	0.11		2.9	$	302

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

The following table summarizes the activities for the Company’s stock options for the year ended December 31, 2019 and 2018:

	Options Outstanding
						Weighted -
						Average
						Remaining		Aggregate
				Weighted-		Contractual		Intrinsic
	Number of			Average		Term		Value (in 000’)
	Shares			Exercise Price		(in years)		(1)
Balance as of December 31, 2017		22,013,529		$	0.11
Granted		1,600,000			0.27
Exercised		(5,000,000	)		0.07
Balance December 31, 2018		18,613,529		$	0.14
Granted		1,500,000		$	0.18
Forfeited/cancelled		(2,200,000	)	$	0.34
Balance December 31, 2019		17,913,529		$	0.12		2.9
Vested and Exercisable at December 31, 2019		16,913,529		$	0.11		2.8	$	60

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period.  During the years ended December 31, 2019 and 2018, the aggregate intrinsic value of options exercised under the Company’s stock option plans was $59,800 and $2,113,368, respectively.

Schedule of summary for the activities of unvested stock options

The following table summarizes the activities for the Company’s unvested stock options for the three months ended March 31, 2020:

	Unvested Options
	Weighted - Average
	Number of Unvested			Grant Date
	Options			Exercise Price
Balance as of December 31, 2019		1,000,000		$	0.20
Granted		4,700,000			0.07
Vested		(3,175,000	)		0.09
Balance as of March 31, 2020		2,525,000		$	0.09

The following table summarizes the activities for the Company’s unvested stock options for the year ended December 31, 2019 and 2018:

	Unvested Options
				Weighted -
				Average
	Number of			Grant
	Unvested Options			Date Exercise Price
Balance December 31, 2017		2,666,667		$	0.06
Granted		1,600,000			0.27
Vested		(2,250,001	)		0.10
Balance December 31, 2018		2,016,666		$	0.18
Granted		1,500,000			0.18
Vested		(2,516,666	)		0.17
Balance December 31, 2019		1,000,000		$	0.20

Schedule of warrant activity

The following table summarizes the activities for the Company’s warrants for the three months ended March 31, 2020:

	Warrants Outstanding
	Number of Shares		Weighted-  Average Exercise Price		Weighted - Average Remaining  Contractual  Term in years)		Aggregate Intrinsic Value (in 000's) (1)
Balance as of December 31, 2019		22,262,608	$	0.31
Granted		24,900,000		0.15
Balance as of March 31, 2020		47,162,608	$	0.23		2.7
Exercisable as of March 31, 2020		47,162,608	$	0.23		2.7	$	-

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.08 for our common stock on March 31, 2020.

The following table summarizes the activities for the Company’s warrants for the year ended December 31, 2019 and 2018: 

	Warrants Outstanding
	Number of Shares			Weighted-  Average  Exercise  Price		Weighted -  Average  Remaining  Contractual  Term  in years)		Aggregate  Intrinsic  Value  (in 000's) (1)
Balance, December 31, 2017		32,292,580		$	0.30
Issued		18,727,769			0.15
Exercised		(22,809,908	)		0.11
Expired		(1,019,608	)		0.07
Cancelled/Forfeited		(4,950,000	)		0.40
Balance, December 31, 2018		22,240,833		$	0.31
Issued		300,000			0.15
Exercised		(200,000	)		0.15
Expired		(78,225	)		0.26
Balance, December 31, 2019		22,262,608		$	0.31		2.8		-
Exercisable at December 31, 2019		22,262,608		$	0.31		2.8		-

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.0699 for our common stock on December 31, 2019.